REGENXBIO Inc. (RGNX)
NASDAQ: RGNX · Real-Time Price · USD
8.91
+0.85 (10.55%)
At close: Aug 25, 2026, 4:00 PM EDT
9.01
+0.10 (1.09%)
After-hours: Aug 25, 2026, 7:30 PM EDT
REGENXBIO Market Cap
REGENXBIO has a market cap or net worth of $588.18 million as of August 25, 2026. Its market cap has increased by 29.24% in one year.
Market Cap
588.18M
Enterprise Value
733.12M
1-Year Change
29.24%
Ranking
Category
Stock Price
$8.91
ChartMarket Cap Chart
Since September 17, 2015, REGENXBIO's market cap has decreased from $749.30M to $588.18M, a decrease of -21.50%. That is a compound annual growth rate of -2.19%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 25, 2026 | 588.20M | -19.31% |
| Dec 31, 2025 | 729.00M | 90.34% |
| Dec 31, 2024 | 383.00M | -51.50% |
| Dec 29, 2023 | 789.70M | -19.57% |
| Dec 30, 2022 | 981.90M | -29.79% |
| Dec 31, 2021 | 1.40B | -17.57% |
| Dec 31, 2020 | 1.70B | 12.32% |
| Dec 31, 2019 | 1.51B | 0.48% |
| Dec 31, 2018 | 1.50B | 45.18% |
| Dec 29, 2017 | 1.04B | 110.87% |
| Dec 30, 2016 | 491.10M | 12.43% |
| Dec 31, 2015 | 436.80M | -41.71% |
| Sep 17, 2015 | 749.30M | - |
View and export this data all the way back to 2015. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| MiMedx Group | 632.60M |
| Arvinas | 627.71M |
| Altimmune | 622.46M |
| Zura Bio | 605.64M |
| Entera Bio | 600.80M |
| Scribe Therapeutics | 588.66M |
| Artiva Biotherapeutics | 575.44M |
| ARS Pharmaceuticals | 568.84M |